Authors
Wanyi Liu, Yuan Zhu, Tao Wang, Yuying Yuan, Xi Yu, Yongqiang Zhu, Peihao Yin, Wei Li, Zeting Yuan
Published in
International journal of nanomedicine. Volume 21. Pages 649895. Epub Nov 03, 2026.
Abstract
Platelets are anucleate blood cells that primarily mediate hemostasis and thrombosis. Tumor metastasis represents the leading cause of mortality among cancer patients, and platelet-mediated hematogenous metastasis constitutes a critical step facilitating the dissemination of tumor cells. A wealth of evidence has demonstrated a close correlation between platelets and tumor progression. Platelets aggregate around circulating tumor cells (CTCs) and drive tumor metastasis via multiple mechanisms: shielding CTCs from hemodynamic shear stress and immune cell attack, inducing epithelial-mesenchymal transition (EMT), promoting the formation of pre-metastatic niches (PMNs), and enabling immune evasion. Targeted therapeutic strategies built on the interplay between platelets and tumors are of great significance for restraining tumor metastasis and prolonging patient survival. This review comprehensively elaborates on the mechanisms by which platelets promote tumor metastasis, summarizes the merits and relevant strategies of platelet-targeted therapies, and offers novel insights for the suppression of tumor metastasis.
PMID:
42999852
Bibliographic data and abstract were imported from PubMed on 08 Nov 2026.
Read full publication at:
Please sign in
to see all details.
Advertisement
Stats
- Recommendations n/a n/a positive of 0 vote(s)
- Views 12
- Comments 0